Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult by Shintaku, Masayuki & Hashimoto, Kenji
CASE REPORT
Anaplastic ependymoma simulating glioblastoma in the cerebrum
of an adult
Masayuki Shintaku • Kenji Hashimoto
Received: 15 April 2011/Accepted: 28 June 2011/Published online: 16 July 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract A case of anaplastic ependymoma of the
cerebral hemisphere in which the histopathological fea-
tures closely simulated those of glioblastoma is reported.
The patient was a 72-year-old woman with a large, well-
demarcated tumor in the left temporal lobe. The tumor
was totally extirpated, but recurred 18 months later, and
the patient died after 4 months. The extirpated tumor was
well circumscribed from the surrounding brain tissue and
consisted of a sheet-like, dense proliferation of atypical,
short spindle or polygonal cells. Extensive geographic
necrosis with nuclear pseudopalisading was seen.
Although perivascular pseudorosettes were observed in
many areas, true ependymal rosettes were absent.
Immunohistochemistry for glial ﬁbrillary acidic protein
and epithelial membrane antigen and ultrastructural study
conﬁrmed the ependymal nature of tumor cells. The his-
topathological spectrum of anaplastic ependymoma is
very wide and reﬂects the basically dual characteristics of
ependymal cells: epithelial and glial phenotypes. The
present case indicates that some anaplastic ependymomas
strongly express the glial phenotype and also show
remarkable anaplastic cytological features, thus closely
simulating glioblastoma. The diagnostic criteria for ana-
plastic ependymoma, and the nosological position of
highly anaplastic ependymoma and its possible clinical
implications, are brieﬂy discussed.
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Introduction
Anaplastic ependymoma is a malignant form of ependy-
moma, and although there was previously some confusion
with ependymoblastoma, it has been recognized as a dis-
tinct clinicopathological entity in the current World Health
Organization (WHO) classiﬁcation of brain tumors [1].
However, because anaplastic ependymoma is a relatively
rare neoplasm and its histopathological spectrum is very
wide, the criteria for the pathological distinction of this
tumor from ordinary ependymoma on the one hand and
from glioblastoma on the other have not yet been estab-
lished. The histopathological basis for grading the malig-
nancy in ependymal neoplasms is not as well established as
that in astrocytic neoplasms.
Considering the relative rarity of this neoplasm and
many unsettled issues surrounding the diagnostic criteria,
pathogenesis, and treatment, further accumulation of
detailed clinico-pathological documentation of individual
cases remains necessary. We report here a primary (de
novo) anaplastic ependymoma in the cerebral hemisphere
of an adult, showing histopathological features closely
resembling those of glioblastoma. The clinico-pathological
issues described above are brieﬂy discussed.
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The patient was a 72-year-old woman who complained of
language disturbance. Starting 2 months prior to consulting
our hospital, she began to experience difﬁculty in under-
standing the names of objects as well as difﬁculty in
ﬁnding adequate words while talking. Because these
symptoms gradually progressed, she was admitted to our
hospital. Mild right hemiparesis and aphasia of mixed type
were noted on admission, and magnetic resonance (MR)
imaging of the head demonstrated a large mass lesion in the
left temporal lobe. The lesion measured about 7 cm in
maximal dimension and had spread from the temporal
cortex to the white matter (Fig. 1). The mass was a rela-
tively well-demarcated, solid and spherical lesion, and
contained a few large cystic areas in the medial region. The
solid portion and the rims of the cystic areas were intensely
enhanced by the administration of contrast medium. Left
parieto-temporal craniotomy was performed under a clini-
cal diagnosis of glioblastoma or anaplastic ependymoma,
and a relatively well-demarcated reddish gray tumor con-
taining cystic areas was extirpated totally. The contiguity
of the tumor to the lateral ventricular wall was conﬁrmed
during surgery. Postoperatively, right hemiparesis disap-
peared, and aphasia improved remarkably. The patient was
treated postoperatively by regional radiation (60 Gy) and
chemotherapy (75 mg/m
2 of temozolomide for 7 weeks),
but local tumor recurrence spreading to the right cerebral
white matter through the corpus callosum was found
18 months later. The recurrent tumor rapidly increased in
size, and left hemiplegia and swallowing difﬁculty
appeared and progressed. The patient died 4 months later at
the age of 74. Permission for autopsy was not obtained.
Pathological ﬁndings
The extirpated tumor was sharply demarcated from the
surrounding cerebral tissue, and the tendency for invasive
growth was scant (Fig. 2). There were no entrapped neu-
rons within the tumor tissue. The tumor was highly cellular
and consisted of a sheet-like, dense proliferation of med-
ium-sized, short spindle or polygonal cells. Conﬂuent,
large, serpentine areas of coagulation necrosis were seen
throughout the tumor, and nuclear pseudopalisading was
prominent around the necrotic areas (Fig. 3). In many
areas, tumor cells were irregularly stratiﬁed around small
blood vessels and formed distinct perivascular pseudoro-
settes (Fig. 4). Tumor cells forming the pseudorosettes
extended long and ﬁne cytoplasmic processes toward the
central blood vessels, and an ‘‘anuclear zone’’ was formed
around the vessels. These pseudorosettes were occasionally
dissociated from each other and formed a growth pattern
resembling a papillary architecture. True ependymal
rosettes or ependymal canals were not detected.
Individual tumor cells had round or elliptical nuclei with
a moderate amount of chromatin. Nuclear atypism and
pleomorphism were marked (Fig. 5), and a few bizarre
giant cells were observed. Mitotic ﬁgures were very com-
mon (about 30 per 10 high-power ﬁelds). The cytoplasm
was palely or densely eosinophilic and relatively abundant.
It was spindle-shaped or polygonal, and exhibited a
Fig. 1 T1-weighted MR image with contrast enhancement. A large,
well-demarcated tumor with cystic changes is seen in the left
temporal lobe. The solid portion and the wall of the cysts are intensely
enhanced
Fig. 2 The boundary between the tumor and the surrounding brain
tissue is clearly demarcated (H&E stain 925)
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had small, short spindle-shaped hyperchromatic nuclei, and
the perinuclear cytoplasm was hardly discernible. Although
proliferation of small to medium-sized blood vessels was
prominent throughout the tumor, there was no apparent
formation of ‘‘glomeruloid structures.’’
Immunohistochemical studies were performed using
Envision Plus detection system (Dako, Glostrup, Denmark)
and employing primary antibodies against the following
substances: glial ﬁbrillary acidic protein (GFAP) (poly-
clonal, Dako, 1:100), epithelial membrane antigen (EMA)
(clone E29, Dako, 1:100), p53 protein (clone DO-7, Dako,
1:100), epidermal growth factor receptor (EGFR) (clone
2-18C9, Dako, prediluted) and Ki67 protein (clone MIB-1,
Dako, 1:100). Most tumor cells were immunoreactive for
GFAP (Fig. 6a), and the cytoplasmic processes forming
pseudorosettes were clearly immunostained. A small
number of tumor cells contained tiny ring- or dot-like
structures immunoreactive for EMA within the cytoplasm
(Fig. 6b). Nuclear immunoreactivity for p53 protein was
observed in about 5% of tumor cells, and only a very small
number of tumor cells showed a faint cytoplasmic immu-
noreactivity for EGFR. Ki67-labeling index was 25.9%.
On ultrastructural examination, tumor cells had irregu-
larly indented, elliptical nuclei with sparse heterochromatin
and prominent nucleoli, and relatively abundant cytoplasm
ﬁlled with well-developed intracytoplasmic organelles.
Some tumor cells contained conglomerates or dense bun-
dles of intermediate ﬁlaments in the perinuclear region or
within the long cytoplasmic processes, respectively
(Fig. 7). The intercellular junctional apparatus was poorly
developed, and there were no long ‘‘zipper-like’’ junctions.
In a few cells, small intracytoplasmic microlumina sur-
rounded by the membrane equipped with poorly developed
microvilli were observed (Fig. 8). Distinct basal lamina
with formation of hemidesmosomes was found on the
surface of tumor cells adjacent to the capillaries.
Discussion
An ependymal cell is a cell that has basically dual mor-
phological and functional characteristics as an epithelial
cell covering the surface of the ventricular system and as a
glial cell that shows alterations closely resembling those of
astrocytes under various pathological conditions [2]. These
dual characteristics are also expressed to varying degrees in
ependymal neoplasms [3]. Anaplastic ependymoma is a
malignant form of ependymoma chieﬂy arising in the
Fig. 3 Conﬂuent, serpentine zones of coagulation necrosis with
nuclear pseudopalisading are seen throughout the tumor (H&E stain
910)
Fig. 4 Distinct perivascular pseudorosettes with the formation of an
‘‘anuclear zone’’ are found in some regions of the tumor. Tumor cells
have hyperchromatic, elliptical nuclei (H&E stain 925)
Fig. 5 In some areas, pleomorphic, polygonal tumor cells show a
sheet-like proliferation. There is an abundance of lymphocytes
between tumor cells in this ﬁeld (H&E stain 950)
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123supratentorial region, and the hemispheric intraparenchy-
mal ependymomas especially show a greater frequency of
histopathological anaplasia than those in the posterior fossa
[4–7]. Pathologically, the dual characteristics of ependymal
cells are retained in anaplastic ependymoma. A case of
anaplastic ependymoma that strongly expressed the epi-
thelial phenotype was reported by Moritani et al. [8]. In
that case, the tumor was composed of large, polygonal,
atypical cells forming a papillary architecture and closely
resembled metastatic papillary adenocarcinoma. In our
case, the glial phenotype of tumor cells was strongly
expressed, and the histopathological appearance closely
resembled that of glioblastoma. Several cases of anaplastic
ependymoma showing a close histopathological resem-
blance to glioblastoma or medulloblastoma have been
described [4, 9, 10], and all of these cases, including those
of Moritani et al. [8] and our own, demonstrate that the
histopathological spectrum of anaplastic ependymoma is
very wide.
The diagnostic criteria of anaplastic ependymoma have
not been well established, and the prognostically predictive
value of each histopathological ﬁnding for ependymal
neoplasm remains unclear. Some investigators claimed that
there is no signiﬁcant relationship between the
Fig. 6 a Tumor cells show
ﬁbrillary immunoreactivity of
the cytoplasm for GFAP. b Dot-
or ring-like immunoreactivity
for EMA is found in a small
number of tumor cells
(immunostaining, a 950,
b 9100)
Fig. 7 Tumor cells have irregular nuclei and abundant cytoplasm
ﬁlled with well-developed organelles and aggregates of densely
packed intermediate ﬁlaments. Intercellular junctional devices are
poorly developed (911,800)
Fig. 8 In the cytoplasm of a few tumor cells, a microlumen
containing a small number of microvilli is found (919,200)
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but other investigators reported a correlation of certain
histopathological features, such as high cell density,
nuclear atypism, an increased mitotic activity, necrosis and
microvascular proliferation, with the rate of recurrence or
length of survival of the patients [5, 6, 10, 13–15]. Ho et al.
[16] proposed diagnostic criteria for anaplastic ependy-
moma employing a scoring system, but the validity and
efﬁcacy of this scoring system remains to be determined.
Many authors regarded increased mitotic activity or high
Ki67 labeling index as the most signiﬁcant correlate with
the prognosis of ependymal neoplasms [10, 13–15, 17, 18].
In the current WHO classiﬁcation, anaplastic ependymoma
is deﬁned as ependymal neoplasms ‘‘characterized by high
mitotic activity, often accompanied by microvascular pro-
liferation and pseudopalisading necrosis,’’ and it is classi-
ﬁed as a grade III tumor [1].
A review of the literature suggests that there are two
pathogenetic pathways of anaplastic ependymoma, similar
to those observed in astrocytic neoplasms, which give rise
to primary (de novo) and secondary (progressive) ana-
plastic ependymoma [1, 6, 19]. The majority appears to
belong to the former category, whereas cases of secondary
anaplastic ependymoma that evolved from ordinary
(benign) ependymoma are recorded infrequently [9, 10].
However, the genetic events that occur in the oncogenetic
processes of anaplastic ependymoma are largely unknown
[1, 19, 20]. In the present case, the nuclear expression of
p53 protein was observed in only about 5% of tumor cells,
and the cytoplasmic expression of EGFR was found only
faintly in a very small number of tumor cells. Although an
increase in p53 nuclear expression by immunohistochem-
istry has been reported in some cases of anaplastic epen-
dymoma [6, 17], p53 mutations are generally considered
uncommon in ependymal neoplasms [1], in contrast to their
common occurrence in diffuse astrocytoma [21]. The role
of EGFR ampliﬁcation in tumor progression has not been
known in ependymoma [20], but Korshunov et al. [6]
reported higher expression of EGFR in anaplastic epen-
dymoma than ordinary ependymoma.
The histopathological appearance of the present tumor
initially suggested a diagnosis of glioblastoma because the
tumor consisted of a sheet-like, dense proliferation of
medium-sized atypical cells showing geographic necrosis
with prominent nuclear pseudopalisading throughout the
tumor. However, the clear demarcation of the neoplasm
from the surrounding brain tissue and the formation of
distinct perivascular pseudorosettes in many areas sug-
gested a diagnosis of anaplastic ependymoma. Differenti-
ation of tumor cells along the ependymal lineage was
conﬁrmed by immunohistochemical and ultrastructural
studies. The absence of cytoplasmic overexpression of
EGFR also helped distinguish the present tumor from
glioblastoma [21]. The nosological position of neoplasms
that show only focal or slight ependymal differentiation on
the overall glioblastoma-like background has not yet been
determined. Some investigators call ependymal neoplasms
showing pseudopalisading necrosis and microvascular
proliferation ‘‘highly anaplastic ependymoma’’ [22]. One
textbook indicates that these tumors should be practically
included within the category of glioblastoma [23].
Although the term ‘‘highly anaplastic ependymoma’’ has
been applied to a variety of anaplastic ependymal neo-
plasms, including those showing predominantly epithelial
differentiation and mimicking adenocarcinoma [8], we
consider that the ‘‘highly anaplastic ependymoma,’’ espe-
cially showing marked glial phenotypes, can be dealt with
in a similar manner to glioblastoma in the daily patho-
logical practice.
The present case indicates that when we encounter a
tumor with prominent pseudopalisading necrosis, a diag-
nosis of anaplastic ependymoma should be considered in
addition to that of glioblastoma, in particular when the
boundary between the tumor and surrounding brain tissue
is distinct. Anaplastic ependymoma is ascribed to grade III
in the current WHO classiﬁcation [1], suggesting a more
favorable clinical outcome than grade IV tumors such as
glioblastoma. However, in our case the recurrent tumor
invaded the contralateral cerebral white matter, spreading
through the corpus callosum, which is a spread pattern
typical of glioblastoma [21, 23]. Anaplastic ependymoma
that histologically resembles glioblastoma may also behave
clinically like glioblastoma. Patients harboring these neo-
plasms may be better treated using modalities similar to
those for patients with glioblastoma.
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